The Enterprise Value as of December 2025 (TTM) for Cognition Therapeutics, Inc. (CGTX) is 119.19M

According to Cognition Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 119.19M. This represents a change of 1.77% compared to the average of 6.38M of the last 4 quarters.

Cognition Therapeutics, Inc. (CGTX) Historical Enterprise Value (quarterly & annually)

How has CGTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Cognition Therapeutics, Inc. over the last ten years is 118.16M. The current 119.19M Enterprise Value has changed 9.99% with respect to the historical average. Over the past ten years (40 quarters), CGTX's Enterprise Value was at its highest in in the September 2021 quarter at 344.02M. The Enterprise Value was at its lowest in in the September 2024 quarter at -2491094.74.

Cognition Therapeutics, Inc. (CGTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cognition Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cognition Therapeutics, Inc. (CGTX) Average Enterprise Value

How has CGTX Enterprise Value performed in the past?

The current Enterprise Value of Cognition Therapeutics, Inc. (CGTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cognition Therapeutics, Inc. (CGTX) Enterprise Value vs. Peers

How is CGTX’s Enterprise Value compared to its peers?

Cognition Therapeutics, Inc.’s Enterprise Value is greater than Tevogen Bio Holdings Inc. (85.88M), greater than VistaGen Therapeutics, Inc. (78.69M), greater than Surrozen, Inc. (73.38M), greater than Seer, Inc. (86.40M), greater than Greenwich LifeSciences, Inc. (118.02M), greater than Atossa Therapeutics, Inc. (40.25M), greater than Spero Therapeutics, Inc. (83.18M), less than Opus Genetics, Inc. (121.30M), less than Agenus Inc. (181.50M), less than Seres Therapeutics, Inc. (194.69M),

Build a custom stock screener for Cognition Therapeutics, Inc. (CGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cognition Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cognition Therapeutics, Inc. (CGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cognition Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.